Report Highlights
The global market for digital biomarkers should grow from $1.8 billion in 2021 to $7.2 billion by 2026, at compound annual growth rate (CAGR) of 31.6% for the period of 2021-2026.
Report Includes
- 56 tables
- An overview of the global markets for digital biomarkers
- Estimation of the market size and analyses of market trends, with data from 2019, 2020, 2021 with projections of compound annual growth rates (CAGRs) through 2026
- Information on major market drivers, opportunities and challenges, industry chain structure, distribution channel, and technological advancements that are affecting the overall marketplace
- Assessment of market potential and revenue forecast for digital biomarkers market based on system component, application, therapeutic area, end user and region
- Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies
- Company profiles of the leading market players including AliveCor, Biogen Inc., Embic Corp., Fitbit, Happify Health, Mindstrong Health, and Winterlight Labs
Report Scope
The current report highlights the current and future market potential of digital biomarkers and also covers market projections to 2026, along with rankings for key market players. It also analyzes the competitive landscape and the regulatory scenario. The report determines the market share of digital biomarkers based on system components, application, therapeutic area and end user. The market by system component is segmented into data collection tools and data integration tools; by application, it is segmented into diagnostic digital biomarkers, monitoring digital biomarkers, predictive digital biomarkers and others; by therapeutic area, it is categorized into cardiovascular and metabolic disorders (CVMD), psychiatric disorders, neurological disorders, respiratory disorders, musculoskeletal disorders and others; and by end user, it is segmented into pharmaceutical companies and research institutions, healthcare providers, payers, employers, patients and caregivers. The report also assesses the impact of the COVID-19 pandemic on this market.
By geography, the market has been segmented into North America, Europe, Asia-Pacific and the rest of the world (RoW). North America consists of the U.S., Canada and Mexico; Europe includes Germany, the U.K., Belgium and Rest of Europe; and Asia-Pacific includes China, Australia, Japan and Rest of Asia-Pacific. For market estimates, data has been provided for the 2019 as the historic year, 2020 as the base year and forecast for 2026.
Report Synopsis
| Report Metrics | Details | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2020 | ||||||||||||||
| Forecast period considered | 2021-2026 | ||||||||||||||
| Base year market size | $1.1 billion | ||||||||||||||
| Market size forecast | $7.2 billion | ||||||||||||||
| Growth rate | CAGR of 31.6% from 2021 to 2026 | ||||||||||||||
| Units considered | $ Millions | ||||||||||||||
| Segments covered | System Component, Application, Therapeutic Area, End User, Region | ||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, Rest of the World (RoW) | ||||||||||||||
| Countries covered | U.S., Canada, Mexico, Germany, France, U.K., Rest of Europe, Japan, China, Australia, Rest of Asia-Pacific, The Middle East and Africa, South America | ||||||||||||||
| Key Market Drivers |
|
||||||||||||||
| Companies studied |
|
||||||||||||||
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- The Global Market for Composites: Resins, Fillers, Reinforcements, Natural Fibers and Nanocomposites (PLS029H)
- Alzheimer's Disease Therapeutics and Diagnostics: Global Markets (PHM062E)
- Impact Modifiers: Global Markets (AVM252A)
- Adhesives and Adhesive-Applying Equipment: Technologies and Global Markets (CHM073E)
- Bioprocess Optimization and Digital Bio-manufacturing: Global Markets (BIO170B)
Related Reports
Wearable Medical Devices: Technologies and Global Markets
The global market for wearable medical devices was valued at $35.6 billion in 2023. This market is estimated to grow from $45.0 billion in 2024 to $151.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.5% from 2024 through 2029.
Oncology Biomarkers: Global Markets
The global oncology biomarkers market reached $15.5 billion in 2022, should reach $17.6 billion by 2023 and $35.2 billion by 2028 with a compound annual growth rate (CAGR) of 14.9% during the forecast period of 2023-2028.
Central Nervous System (CNS) Biomarkers: Technologies and Global Markets
The global central nervous system (CNS) biomarkers market should reach $9.5 billion by 2027 from $5.7 billion in 2022 at a compound annual growth rate (CAGR) of 10.8% for the forecast period of 2022 to 2027.
Fitness Apps: Global Market Size, Share & Growth Forecast
The global market for fitness apps is estimated to increase from $15.0 billion in 2022 to reach $34.3 billion by 2027, at a compound annual growth rate (CAGR) of 18.1% from 2022 through 2027.
Recent Reports
Bioprocess Optimization and Digital Bio-manufacturing: Global Markets
The global market for bioprocess optimization and digital biomanufacturing is expected to grow from $24.3 billion in 2024 and is projected to reach $39.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2024 to 2029.
Global DNA Sequencing: Research, Applied and Clinical Markets
The global market for DNA sequencing is expected to grow from $14.8 billion in 2024 and is projected to reach $34.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 18.6% during the forecast period of 2024 to 2029.
Artificial Intelligence (AI) in Cancer
The global market for artificial intelligence (AI) in cancer is estimated to increase from $2.2 billion in 2024 to reach $6.3 billion by 2029, at a compound annual growth rate (CAGR) of 23.1% from 2024 through 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More